uploads///business _

Wall Street Expects 9% Upside Potential for UnitedHealth Stock

By

Sep. 25 2018, Updated 11:02 a.m. ET

Analysts’ views on UnitedHealth Group

UnitedHealth Group (UNH) is one of the largest Fortune 500 companies. It’s the largest health insurer in the United States. The company operates across two divisions: UnitedHealthcare and Optum. In this part of the series, we’ll look at analysts’ recommendations for UNH stock.

As of September 24, according to a Reuters survey of 24 analysts covering UNH stock, ten analysts have recommended a “strong buy,” and 13 have recommended a “buy.” Only one analyst has recommended a “hold.” None of the analysts have rated the stock a “sell.”

Article continues below advertisement

Target prices

According to these analysts, the consensus target price for UNH stock is $290.62. That represents a return of ~8.7% for the next 12 months based on UNH’s closing price of $267.36 on September 24.

Analysts’ average target prices for peers Aetna (AET), Cigna (CI), and Anthem (ANTM) are $203.73, $225.61, and $299.05, respectively. Those target prices imply 12-month return potentials of 0.16%, 11%, and 9.5%, respectively.

Advertisement

More From Market Realist

    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.